OprF-OprI vaccine (Valneva)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameOprF-OprI vaccine (Valneva)

Drug Alias NameOprF-OprI疫苗 - ValnevaOprF-OprI vaccinePseudomonas aeruginosa vaccine (Valneva)OprF-OprIVLA-43 +[10]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumonia, Ventilator-AssociatedPseudomonas Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechiaBelgiumHungary +[6]

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsPneumonia, Ventilator-AssociatedPseudomonas Infections

ATC CodeN/A